Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0000905148-24-003015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-07 | IRD | YERXA BENJAMIN R | Pres, Dir | A - Grant | $0.00 | +332.8K | 332.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | A | A | 332,800 | $0.00 | 332,800 | D | — | — | (F1) Represents a grant of restricted stock units which vest in four equal installments on the first, second, third, and fourth anniversary of October 22, 2024, subject to the Reporting Person's continuing service. |